UNSPSC 51285402: Cefedrolor

This classification denotes a cephalosporin antibiotic with the molecular formula C16H16ClN3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) O3TY87KJII, chemically known as (6r,7r)-7-((r)-2-amino-2-(3-chloro-4-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid. but more generally known as cefedrolor, which bears US NIH Compound Identifier 193953.

UNSPSC 51285402 Cefedrolor, a Commodity code, does not align with recent state and local procurement activity tagged under this classification. The source records show no solicitations for cefedrolor or related cephalosporin antibiotics; instead, the opportunities posted under this code span naloxone procurement, pharmaceutical benefit management infrastructure, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals through cooperative purchasing vehicles. The mismatch suggests either a tagging error in the source data or dormant procurement activity under the cefedrolor code at the state and local level.

The four recent opportunities reflect activity across different government sectors and geographies. Seminole County, Florida issued an IFB (due July 26, 2023) for naloxone and drug deactivation systems totaling 1,900 and 800 units annually for community health. The City of Tampa issued a sealed-bid solicitation (due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000, with a Small Local Business Enterprise set-aside and 5% bid discount. The Texas Health and Human Services Commission posted an RFI (due April 3, 2026) exploring direct-to-manufacturer prescription programs outside traditional PBM channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with awards effective July 1, 2026. Activity spans Florida, Texas, and Minnesota, with cooperative purchasing vehicles serving broader multistate participation. No recent opportunities specifically target cefedrolor or demonstrate active state and local demand under this code.